Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Triple Negative Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07256964
What this trial is testing

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Henan Cancer Hospital 216
Early research (Phase 1)Looking for participantsNCT06324240
What this trial is testing

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+24 more
Emory University 18
Testing effectiveness (Phase 2)Looking for participantsNCT06817525
What this trial is testing

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 64
Testing effectiveness (Phase 2)Study completedNCT01672671
What this trial is testing

BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

Who this might be right for
Early Triple Negative Breast Cancer
Russian Academy of Medical Sciences 41
Not applicableStudy completedNCT05730010
What this trial is testing

Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

Who this might be right for
Triple Negative Breast Cancer
Indiana University 289
Not applicableLooking for participantsNCT07216495
What this trial is testing

Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC

Who this might be right for
Aerobic ExerciseEarly Stage Triple Negative Breast Cancer
M.D. Anderson Cancer Center 33
Early research (Phase 1)Looking for participantsNCT07178171
What this trial is testing

QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
Xijing Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05455658
What this trial is testing

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+14 more
University of Washington 33
Testing effectiveness (Phase 2)Looking for participantsNCT06797635
What this trial is testing

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Who this might be right for
Breast NeoplasmsBreast Cancer
Merck Sharp & Dohme LLC 372
Not applicableLooking for participantsNCT06225505
What this trial is testing

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Who this might be right for
Triple Negative Breast Cancer
Institut Curie 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT03546686
What this trial is testing

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Large-scale testing (Phase 3)Study completedNCT00789581
What this trial is testing

Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 614
Early research (Phase 1)Study completedNCT02950259
What this trial is testing

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Who this might be right for
Breast NeoplasmBreast Neoplasm, MaleTriple Negative Breast Cancer
Providence Health & Services 16
Not applicableLooking for participantsNCT07773818
What this trial is testing

Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study

Who this might be right for
Triple -Negative Breast CancertripleMeta-LearningPredictive Models+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 32
Not applicableActive Not RecruitingNCT07484776
What this trial is testing

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Universidad Europea de Madrid 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07271992
What this trial is testing

TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer

Who this might be right for
TNBC, Triple Negative Breast Cancer
First Hospital of China Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05020860
What this trial is testing

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmBreast Cancer Female+8 more
Baylor Breast Care Center 185
Testing effectiveness (Phase 2)UnknownNCT04739670
What this trial is testing

Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
Peter MacCallum Cancer Centre, Australia 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07552181
What this trial is testing

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast CancerTNBCEarly Stage Triple-Negative Breast Carcinoma
Yuan Yuan 50
Next Page